GRAIL, Inc. (GRAL)
112.52
+4.00
(+3.69%)
USD |
NASDAQ |
Sep 24, 11:32
GRAIL Price : 112.52 for Sept. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | 108.52 | 108.52 | 108.52 | 108.52 | 1075.00 |
| Sep 22, 2026 | 106.75 | 112.58 | 104.00 | 108.52 | 3.261M |
| Sep 21, 2026 | 93.74 | 111.50 | 92.00 | 107.97 | 3.529M |
| Sep 18, 2026 | 81.48 | 82.85 | 78.20 | 80.77 | 3.004M |
| Sep 17, 2026 | 75.29 | 81.76 | 75.29 | 79.95 | 1.529M |
| Sep 16, 2026 | 75.95 | 78.86 | 74.12 | 75.11 | 1.615M |
| Sep 15, 2026 | 75.44 | 77.93 | 74.27 | 75.89 | 1.515M |
| Sep 14, 2026 | 74.68 | 76.56 | 73.46 | 75.53 | 1.146M |
| Sep 11, 2026 | 77.61 | 79.19 | 76.14 | 76.23 | 360985.0 |
| Sep 10, 2026 | 75.93 | 79.00 | 75.09 | 77.56 | 897064.0 |
| Sep 09, 2026 | 78.96 | 81.18 | 76.99 | 77.48 | 591087.0 |
| Sep 08, 2026 | 80.19 | 81.71 | 78.85 | 79.10 | 693593.0 |
| Sep 04, 2026 | 79.92 | 80.51 | 78.50 | 80.34 | 434820.0 |
| Sep 03, 2026 | 81.33 | 82.61 | 79.21 | 80.62 | 320586.0 |
| Sep 02, 2026 | 80.00 | 83.00 | 78.98 | 80.56 | 449188.0 |
| Sep 01, 2026 | 79.00 | 80.79 | 77.74 | 79.79 | 467186.0 |
| Aug 31, 2026 | 79.00 | 80.17 | 76.60 | 79.37 | 555941.0 |
| Aug 28, 2026 | 80.18 | 82.32 | 77.70 | 80.00 | 658514.0 |
| Aug 27, 2026 | 79.00 | 85.49 | 78.00 | 82.50 | 742984.0 |
| Aug 26, 2026 | 80.88 | 82.25 | 78.34 | 79.59 | 396871.0 |
| Aug 25, 2026 | 78.24 | 84.49 | 76.63 | 82.54 | 658686.0 |
| Aug 24, 2026 | 81.87 | 81.87 | 75.61 | 76.58 | 381019.0 |
| Aug 21, 2026 | 78.88 | 80.76 | 76.15 | 79.54 | 605055.0 |
| Aug 20, 2026 | 73.77 | 81.85 | 73.77 | 77.97 | 1.350M |
| Aug 19, 2026 | 73.56 | 77.12 | 72.20 | 73.96 | 1.098M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 65.60 |
| Oncolytics Biotech, Inc. | 0.6535 |
| Sangamo Therapeutics, Inc. | 0.1486 |
| Sarepta Therapeutics, Inc. | 18.21 |
| Anixa Biosciences, Inc. | 2.75 |
Price Related Metrics
| PS Ratio | 27.34 |
| Price to Book Value | 1.977 |
| Earnings Yield | -8.66% |
| Market Cap | 5.026B |